Kyverna therapeutics inc. may be liable to compensate investors and those with losses should contact the schall law firm about an inquiry

Los angeles, ca / accesswire / september 2, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of kyverna therapeutics, inc. ("kyverna" or "the company") (nasdaq:kytx) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
KYTX Ratings Summary
KYTX Quant Ranking